2,639 results match your criteria Acute Febrile Neutrophilic Dermatosis

Bullous Sweet Syndrome.

Indian J Hematol Blood Transfus 2022 Jul 4;38(3):612-613. Epub 2022 Jan 4.

Pathology Service, Lozano Blesa University Hospital, Zaragoza, Spain.

View Article and Full-Text PDF

[Analysis of prescription and medication rules of traditional Chinese medicine in the treatment of the coronavirus disease 2019 based on traditional Chinese medicine inheritance support platform].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2022 May;34(5):454-458

Department of Encephalopathy, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang 050011, Hebei, China. Corresponding author: Mei Jianqiang, Email:

Objective: To analyze the rules of medication and principles of formulas for the treatment of coronavirus disease 2019 (COVID-19) using the traditional Chinese medicine inheritance support platform (V2.5).

Methods: The clinical data, including gender, age, clinical symptoms, frequency of traditional Chinese medicine medication and prescription information, of patients with COVID-19 and asymptomatic infection who were admitted to Hebei COVID-19 designated hospital supported by medical team of First Affiliated Hospital of Hebei University of Chinese Medicine from January to March 2021 were collected. Read More

View Article and Full-Text PDF

Chemotherapy-induced Sweet's syndrome in a patient with recurrent laryngeal carcinoma.

BMJ Case Rep 2022 06 20;15(6). Epub 2022 Jun 20.

Dermatology Department, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.

View Article and Full-Text PDF

Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine.

J Eur Acad Dermatol Venereol 2022 Jun 20. Epub 2022 Jun 20.

Dermatology department, Fattouma Bourguiba Hospital, Dermo-Respiratory Research Laboratory UR14 SP 03,University of Medicine, Monastir, Tunisia.

View Article and Full-Text PDF

Neutrophilic Dermatoses in a Clinical Practice of Wound Care Professionals.

Adv Skin Wound Care 2022 Jun;35(6):1-8

Tatiana Lapa, MD, MScCH, is Master's Student, Dalla Lana School of Public Health, University of Toronto, Clinical Practicum Placement, Toronto Regional Wound Healing Clinic, International Interprofessional Wound Care Course, Toronto, Ontario, Canada. R. Gary Sibbald, MD, DSc (Hons), MEd, BSc, FRCPC (Med Derm), MACP, FAAD, MAPWCA, is Professor, Division of Dermatology, Department of Medicine, and Dalla Lana School of Public Health, University of Toronto, and Women's College Hospital, Toronto. Patricia M. Coutts, RN, is Wound Care & Clinical Trials Coordinator, Toronto Regional Wound Healing Clinic and Faculty, International Interprofessional Wound Care Course. Xiu Chang Zhao, MD, CCFP, is Family Physician, Trillium Health Partners, Mississauga, Ontario. The authors have disclosed no financial relationships related to this article. Submitted June 7, 2021; accepted in revised form July 26, 2021.

Abstract: Diagnosing and treating neutrophilic dermatoses (NDs) in clinical practice can be challenging because of various presentations and stubborn treatment responses. Establishing a diagnosis is necessary, though, because many NDs are associated with underlying conditions, including malignancy. In this article, the authors provide information about Sweet syndrome, pyoderma gangrenosum, and other NDs and describe their clinical presentation, pathophysiology, diagnostic criteria, and associated conditions. Read More

View Article and Full-Text PDF

Line-field confocal optical coherence tomography (LC-OCT) as a new tool for non-invasive differential diagnosis of pustular skin disorders.

J Eur Acad Dermatol Venereol 2022 Jun 13. Epub 2022 Jun 13.

Dermatology Unit and Skin Bank, Department of Medical, Surgical and Neurosciences, Siena University Hospital, Siena, Italy.

Background: The spectrum of pustular skin disorders (PSD) is large and particularly challenging, including inflammatory, infectious and amicrobial diseases. Moreover, although pustules represent the unifying clinical feature, they can be absent or not fully developed in the early stage of the disease. The line-field confocal optical coherence tomography (LC-OCT) is a recently developed imaging technique able to perform a non-invasive, in vivo, examination of the epidermis and upper dermis, reaching very high image resolution and virtual histology. Read More

View Article and Full-Text PDF

Sweet's syndrome and Crohn's disease diagnosed simultaneously.

Lancet 2022 06;399(10341):2155

Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article and Full-Text PDF

Subcutaneous Sweet syndrome leading to the diagnosis of acute myeloid leukaemia.

Aust J Gen Pract 2022 06;51(6):391-393

MBBS, FACD, Head, Department of Dermatology, Concord Repatriation General Hospital, Sydney, NSW; Clinical Senior Lecturer, University of Sydney, Sydney, NSW.

View Article and Full-Text PDF

Current Hydration Habits: The Disregarded Factor for the Development of Renal and Cardiometabolic Diseases.

Nutrients 2022 May 15;14(10). Epub 2022 May 15.

Department Cardio-Renal Physiopathology, INC Ignacio Chávez, Mexico City 14080, Mexico.

Improper hydration habits are commonly disregarded as a risk factor for the development of chronic diseases. Consuming an intake of water below recommendations (underhydration) in addition to the substitution of sugar-sweetened beverages (SSB) for water are habits deeply ingrained in several countries. This behavior is due to voluntary and involuntary dehydration; and because young children are exposed to SSB, the preference for a sweet taste is profoundly implanted in the brain. Read More

View Article and Full-Text PDF

Renin-Angiotensin System Pathway Therapeutics Associated With Improved Outcomes in Males Hospitalized With COVID-19.

Crit Care Med 2022 May 19. Epub 2022 May 19.

Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.

Objectives: To determine whether angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme (ACE) inhibitors are associated with improved outcomes in hospitalized patients with COVID-19 according to sex and to report sex-related differences in renin-angiotensin system (RAS) components.

Design: Prospective observational cohort study comparing the effects of ARB or ACE inhibitors versus no ARBs or ACE inhibitors in males versus females. Severe acute respiratory syndrome coronavirus 2 downregulates ACE-2, potentially increasing angiotensin II (a pro-inflammatory vasoconstrictor). Read More

View Article and Full-Text PDF

Photosensitive Sweet syndrome: An uncommon entity.

Indian J Dermatol Venereol Leprol 2022 Apr 5:1-3. Epub 2022 Apr 5.

Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

View Article and Full-Text PDF

Recurrent palmar erythematous plaques with pseudovesicles: Sweet's syndrome affecting palms only.

Arun Inamadar

BMJ Case Rep 2022 05 19;15(5). Epub 2022 May 19.

Department of Dermatology, Venereology & Leprosy, Shri BM Patil Medical College, Vijayapur, Karnataka, India

View Article and Full-Text PDF

-GlcNAcylation: A Sweet Hub in the Regulation of Glucose Metabolism in Health and Disease.

Front Endocrinol (Lausanne) 2022 22;13:873513. Epub 2022 Apr 22.

Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.

-GlcNAcylation is a posttranslational modification ruled by the activity of a single pair of enzymes, -GlcNAc transferase (OGT) and -GlcNAcase (OGA). These two enzymes carry out the dynamic cycling of -GlcNAcylation on a wide range of cytosolic, nuclear, and mitochondrial proteins in a nutrient- and stress-responsive manner. To maintain proper glucose homeostasis, a precise mechanism to sense blood glucose levels is required, to adapt cell physiology to fluctuations in nutrient intake to maintain glycemia within a narrow range. Read More

View Article and Full-Text PDF

Unusual presentation of Sweet's syndrome involving palms and its dermoscopy.

BMJ Case Rep 2022 05 3;15(5). Epub 2022 May 3.

Department of Dermatology, Venereology & Leprosy, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

View Article and Full-Text PDF

A Rare Case of Midostaurin-Associated Sweet's Syndrome.

Case Rep Hematol 2022 22;2022:1099005. Epub 2022 Apr 22.

University of Iowa Health Care, Iowa City, Iowa, USA.

Acute febrile neutrophilic dermatosis which is referred as Sweet's syndrome (SS) is a dermatological condition characterized by fever, erythematous rash, and leukocytosis. SS can be idiopathic or associated with malignancies or medications. We present a rare case of SS which developed shortly after starting midostaurin in a patient with acute myelogenous leukemia (AML). Read More

View Article and Full-Text PDF


Med Clin North Am 2022 May 4;106(3):411-422. Epub 2022 Apr 4.

UC Davis Health, 4150 V Street, Suite 2400, Sacramento, CA 95817, USA.

Malignancy is the second leading cause of death in the United States, following heart disease. In most cancers, early detection is one of the most important factors in determining prognosis. As clinicians it is therefore important to be aware of potential clues of underlying malignancy on physical examination. Read More

View Article and Full-Text PDF

Characteristics of Sweet syndrome in patients with or without malignancy.

Ann Hematol 2022 Jul 28;101(7):1499-1508. Epub 2022 Apr 28.

Department of Internal Medicine, Seoul National University Hospital, Biomedical Research Institute, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 03080, South Korea.

Sweet syndrome is a neutrophilic dermatosis occasionally associated with malignancies. Due to its rarity, the clinical features of Sweet syndrome are still unclear. Thus, we aimed to analyze clinical features, treatment, and outcomes of these patients according to associated disease. Read More

View Article and Full-Text PDF

IDH1 inhibitor-induced neutrophilic dermatosis in a patient with acute myeloid leukemia.

Cancer Treat Res Commun 2022 14;31:100560. Epub 2022 Apr 14.

Div of Hematology/Oncology, Dept of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address:

Ivosidenib is an oral inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1). It is approved for treatment of patients with relapsed or refractory IDH1-mutated acute myeloid leukemia (AML) and patients with newly diagnosed IDH1-mutated AML who are 75 years or older or those who are ineligible to receive intensive chemotherapy. While generally well tolerated, differentiation syndrome has been reported in 15-20% of patients. Read More

View Article and Full-Text PDF

Granulocyte colony-stimulating factor as a cause of acute leucocytoclastic vasculitis with anti-Ro and anti-La antibodies.

BMJ Case Rep 2022 Apr 22;15(4). Epub 2022 Apr 22.

Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Granulocyte colony-stimulating factor (G-CSF) administration is associated with a diverse range of cutaneous sequelae. Serious dermatological side effects of G-CSF include the development of Sweet's syndrome and exacerbations of pre-existing inflammatory disorders such as psoriasis. Here, we describe a report of acute leucocytoclastic vasculitis caused by G-CSF therapy associated with anti-Ro and anti-La antibodies in a patient with multiple myeloma. Read More

View Article and Full-Text PDF

Chronic recurrent annular neutrophilic dermatosis: A rare entity.

Clin Case Rep 2022 Apr 18;10(4):e05771. Epub 2022 Apr 18.

Dermatology Department Fattouma Bourguiba University Hospital University of Monastir Monastir Tunisia.

We report a new case of chronic recurrent annular neutrophilic dermatosis in a woman. Through our observation, we aim to make the clinician aware of this rare entity, in order to consider it among the diagnostic hypotheses of annular dermatosis, with centrifugal, recurrent, and chronic evolution. Read More

View Article and Full-Text PDF

Photodistributed pustular acute febrile neutrophilic dermatosis revealing an acute myeloid leukemia.

Clin Case Rep 2022 Apr 5;10(4):e05702. Epub 2022 Apr 5.

Department of Dermatology Fattouma Bourguiba Hospital Monastir Tunisia.

Sweet syndrome is a rare inflammatory dermatosis that can be associated with various diseases, including leukemias. Physicians should be aware that a photodistributed clinical presentation of a pustular SS may reveal underlying malignancies, particularly hemopathies. If the hemopathy is known, recurrence lesions should be suspected of a relapse. Read More

View Article and Full-Text PDF

Endoscopic management of candy cane syndrome: A sweet and attractive solution?

Gastrointest Endosc 2022 Jun 8;95(6):1254-1255. Epub 2022 Apr 8.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

View Article and Full-Text PDF

Deep Sweet Syndrome Secondary to Pegfilgrastim.

J Drugs Dermatol 2022 Apr;21(4):422-424

Sweet syndrome, or acute febrile neutrophilic dermatosis, is a skin condition consisting of erythematous papules and plaques in association with fever, neutrophilia, and a neutrophilic infiltrate that typically involves the papillary dermis. Although development is most commonly idiopathic, medications are also frequently associated with the eruption, notably, the granulocyte colony-stimulating factor (G-CSF), filgrastim. Pegylated G-CSF, despite similar activity, is not commonly reported, with only four published cases. Read More

View Article and Full-Text PDF

Sterile Neutrophilic Dermatosis (Sweet's Syndrome) Associated With Systemic Inflammatory Response Syndrome in a Maltese Dog: A Case Report.

Front Vet Sci 2022 21;9:837942. Epub 2022 Mar 21.

College of Veterinary Medicine, Gyeongsang National University, Jinju, South Korea.

We report a rare case of sterile neutrophilic dermatosis (Sweet's syndrome) accompanied by systemic inflammatory response syndrome. A 5-year-old, neutered male Maltese dog presented with extensive crusts on the whole-body surface and multifocal erosions and plaques on the four limbs. The lesions had been present for two months and did not respond to antibiotics before the presentation. Read More

View Article and Full-Text PDF

Sweet syndrome: a retrospective analysis of 16 patients from a tertiary care center.

Int J Dermatol 2022 Apr 5. Epub 2022 Apr 5.

Department of Dermatology, Beaumont Hospital, Dublin, Ireland.

View Article and Full-Text PDF

Sweet Syndrome in the Pediatric Population.

Dermatol Clin 2022 Apr 4;40(2):179-190. Epub 2022 Mar 4.

Department of Dermatology, Oregon Health and Science Univeristy, 3303 South Bond Avenue, Center for Health and Healing Building 1, 16th Floor, Portland, OR 97239, USA. Electronic address:

Pediatric Sweet syndrome (SS) is thought to be a hypersensitivity reaction to an underlying inflammatory or infectious state and typically is diagnosed using criteria created for adult patients. Although more studies are needed to understand the etiology and natural course of pediatric SS, guidelines for work-up and treatment have been suggested. Herein, the available literature is reviewed and guidelines summarized for the clinical evaluation and management of pediatric SS. Read More

View Article and Full-Text PDF

Not So Sweet Sweet's Syndrome: A Case of Acute Febrile Neutrophilic Dermatosis in the Treatment of Ovarian Carcinoma.

Gynecol Oncol Rep 2022 Apr 14;40:100947. Epub 2022 Mar 14.

University of Illinois College of Medicine Peoria, United States.

Background: Acute febrile neutrophilic dermatosis, or Sweet's Syndrome (SS), was first characterized by Dr. Robert Sweet in 1964 with eight cases of fever, neutrophilic polymorphonuclear leukocytosis, dermatological lesions, and histological evidence of dense dermal infiltration by mature neutrophils. SS presents in three settings: idiopathic, malignancy-associated, and drug-induced. Read More

View Article and Full-Text PDF